Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Gibb

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 15, 2020
Acceptability of a first-line anti-tuberculosis formulation for children: qualitative data from the SHINE trialD T Wademan, L Busakwe, T J Nicholson, et al.
BMC Health Services Research|November 30, 2015
Population level usage of health services, and HIV testing and care, prior to decentralization of antiretroviral therapy in Agago District in rural Northern UgandaG Abongomera, S Kiwuwa-Muyingo, P Revill, et al.
AIDS (London, England)|April 26, 2007
Lamivudine/abacavir maintains virological superiority over zidovudine/lamivudine and zidovudine/abacavir beyond 5 years in childrenH Green, D M Gibb, A S Walker, et al.
Clinical Pharmacology and Therapeutics|March 3, 2007
Age-dependent pharmacokinetics of lamivudine in HIV-infected childrenD M Burger, G Verweel, N Rakhmanina, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2017
Risk in the "Red Zone": Outcomes for Children Admitted to Ebola Holding Units in Sierra Leone Without Ebola Virus DiseaseF Fitzgerald, K Wing, A Naveed, et al.
Journal of Virus Eradication|February 20, 2016
The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected childrenP Palma, C Foster, P Rojo, et al.
AIDS (London, England)|April 14, 2010
Discordance between CD4 cell count and CD4 cell percentage: implications for when to start antiretroviral therapy in HIV-1 infected children, K Boyd, David T Dunn, et al.
HIV Medicine|September 15, 2016
Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in EuropeA Judd, R Lodwick, A Noguera-Julian, et al.
Lancet (London, England)|December 17, 2009
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial, P Mugyenyi, A S Walker, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 15, 2020
Acceptability of a first-line anti-tuberculosis formulation for children: qualitative data from the SHINE trialD T Wademan, L Busakwe, T J Nicholson, et al.
BMC Health Services Research|November 30, 2015
Population level usage of health services, and HIV testing and care, prior to decentralization of antiretroviral therapy in Agago District in rural Northern UgandaG Abongomera, S Kiwuwa-Muyingo, P Revill, et al.
AIDS (London, England)|April 26, 2007
Lamivudine/abacavir maintains virological superiority over zidovudine/lamivudine and zidovudine/abacavir beyond 5 years in childrenH Green, D M Gibb, A S Walker, et al.
Clinical Pharmacology and Therapeutics|March 3, 2007
Age-dependent pharmacokinetics of lamivudine in HIV-infected childrenD M Burger, G Verweel, N Rakhmanina, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2017
Risk in the "Red Zone": Outcomes for Children Admitted to Ebola Holding Units in Sierra Leone Without Ebola Virus DiseaseF Fitzgerald, K Wing, A Naveed, et al.
Journal of Virus Eradication|February 20, 2016
The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected childrenP Palma, C Foster, P Rojo, et al.
AIDS (London, England)|April 14, 2010
Discordance between CD4 cell count and CD4 cell percentage: implications for when to start antiretroviral therapy in HIV-1 infected children, K Boyd, David T Dunn, et al.
HIV Medicine|September 15, 2016
Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in EuropeA Judd, R Lodwick, A Noguera-Julian, et al.
Lancet (London, England)|December 17, 2009
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial, P Mugyenyi, A S Walker, et al.
Pageof 10